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Abstract
Background: Raynaud’s phenomenon is a microvascular disorder that results in exaggerated vasoconstriction over
vasodilatation secondary to an alteration in autonomic control. Though benign, it can result in severe ulceration
and ultimately gangrene associated with disfiguration and permanent deformity. We present a case of severe
secondary Raynaud’s phenomenon in a black-African patient from a resource-limited setting, with focus on the
difficulties encountered in the diagnosis and treatment.
Case presentation: A 43-year-old female Cameroonian farmer with a 7-year history of episodic paresthesia in her
fingers and toes (when exposed to cold) presented to our emergency department with severe pain, ulceration, and
“darkening” of her fingertips over a period of 2 days. An examination revealed bilateral ulceration and dry gangrene
of her fingers and toes, based on which a diagnosis of secondary Raynaud’s phenomenon due to a connective
tissue disease was proposed. Results of paraclinical investigations were normal. Lifestyle modification along with a
calcium channel blocker and phosphodiesterase type 5 inhibitor provided significant relief.
Conclusions: An early diagnosis and knowledge on appropriate treatment of Raynaud’s phenomenon is of vital
importance to prevent permanent tissue damage and disability. Relying on biphasic color change for the diagnosis
of Raynaud’s phenomenon in black Africans can be potentially misleading.
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Background
Raynaud’s phenomenon (RP) is a microvascular disorder
generally involving the digits and other extremities such
as the nose, ears, and nipples [1]. This phenomenon was
first described in 1862 by the French physician Maurice
Raynaud [2]. In extreme severity it can lead to ulceration
and gangrene of the affected extremities, resulting in dis-
figuration and permanent disability. Herein, we describe
a case of severe secondary RP in a black African woman
from a resource-limited setting, and we discuss the diffi-
culties encountered in the diagnosis and management.
Case presentation
A 43-year-old female Cameroonian farmer presented to
our emergency department with pain, ulceration, and
“darkening” of her fingers and feet of 2 days’ duration.
The pain was mild in intensity at the onset, then pro-
gressively worsened over 2 days. She took self-prescribed
doses of diclofenac that temporarily relieved the pain.
Resurgence of the pain with the onset of ulceration mo-
tivated her present consultation. Her past history was re-
markable for episodic “pins and needles” sensation of
the fingers aggravated by cold (mostly cold weather and
immersion of hands in cold water). She had bilateral
knee and elbow joint pain, but no color changes of her
digits prior to the onset of ulceration and gangrene. On
physical examination, she was anxious and in painful
distress with a blood pressure of 156/94 mmHg, a pulse
rate of 94 beats per minute, a respiratory rate of 28 cycles
per minute, and a temperature of 37.4 °C. There were
dry gangrenous lesions affecting the distal third of the
middle, ring, and small finger of her left hand and the
second finger of her right hand (Fig. 1), and the distal
extremity of her feet (Fig. 2). No other cutaneous lesions
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were observed. The rest of the physical examination was
not contributory. A presumptive diagnosis of severe sec-
ondary RP due to a connective tissue disease was made.
Her erythrocyte sedimentation rate (ESR), fasting blood
sugar, anti-streptolysin O antigen (ASLO) level, human im-
munodeficiency virus (HIV) serology, urine analysis, and
rheumatoid factor concentration were all negative. A
Doppler ultrasonography of her peripheral blood vessels
was normal. Blood samples for anti-nuclear antibodies
(ANA) and anti-topoisomerase (anti-Scl 70) antibodies
were collected and preserved to be sent abroad for analysis,
though plans fell through due to financial constraints.
Fig. 1 Dorsal and palmar view of ulceration and gangrene of the distal third of the right index finger (left), and the distal third fingers of the left
hand (right)
Fig. 2 Symmetric affection with ulceration and gangrene of the toes
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We admitted her to our intensive care unit. Non-
pharmacological treatment included stopping diclofenac
(and other prostaglandin inhibitors); putting on warm
clothing; placing her hands and feet in lukewarm water;
and avoiding consumption of caffeine-containing prod-
ucts, cold exposure, and smoking (active or passive).
Pharmacological measures included nifedipine, 20 mg
per os thrice daily; sildenafil, 15 mg per os thrice daily;
cloxacillin, 500 mg thrice daily; tramadol, 100 mg start
dose given intravenously; and open dressing of her ul-
cers. Complete analgesia was achieved within 45 minutes
and, after 3 days of inpatient management, our patient
was stable and referred to a rheumatologist for further
management but was lost to follow-up.
Discussion
Globally, primary RP is fairly common with a prevalence
of 3–5% predominantly in cold climates [1]. The preva-
lence of secondary RP depends on the associated disease,
reaching up to 90% in patients with systemic sclerosis
[3]. No epidemiologic data on this phenomenon is avail-
able in Africa.
The following have been suggested as driving factors
in RP: cold (most common), emotional stress, drugs
such as beta blockers, prolonged use of digits (like pro-
longed typing and piano playing), smoking, and the pres-
ence of an underlying vascular disease [1]. Cold and
farming (associated with prolonged use of digits) were
most likely the trigger factors of our patient’s crisis, with
possible aggravation by diclofenac, which inhibits prosta-
glandin synthesis by inhibiting cyclo-oxygenase.
RP results from an exaggeration of vasoconstriction of
the pre-arteriolar capillaries over vasodilatation, second-
ary to an alteration in the neurological control of the
vasomotor tone and circulating mediators [4]. The auto-
nomic nervous system overreacts and overproduces
endothelin 1 (a potent vasoconstrictor also associated
with vascular fibrosis) with respect to prostaglandin E2
[PG E2 (a vasodilator)], leading to excessive vasocon-
striction [5]. This results in the episodic and symmetrical
triphasic color change (pallor, cyanosis, and rubor),
trophic skin changes, and uncomfortable sensory symp-
toms in the involved extremities (paresthesia in our case)
[6]. On exposure to cold, the distal finger pads initially
become pale as a result of vasoconstriction, then cyan-
osis occurs, secondary to tissue hypoxia, and finally they
turn red, as tissue reperfusion occurs [1]. RP has been
classified clinically into two types: primary RP, which is
mostly benign; and secondary RP, which in 10–20% of
cases is associated with an underlying systemic dis-
ease [such as Sjören’s syndrome, systemic sclerosis,
CREST syndrome (calcinosis, RP, esophageal dysmoti-
lity, sclerodactyly, and telangiectasia), systemic lupus
erythematosus, or dermatomyositis], or with drugs or
extrinsic vascular obstruction [7]. Primary RP is character-
ized by symmetrical attacks on the digits in the absence of
peripheral vascular disease, tissues necrosis, ulceration, or
gangrene [2, 8]. Meanwhile, the attacks of secondary RP
are associated with more severe asymmetric affection with
tissue necrosis, ulceration, and gangrene [2, 8]. Sclero-
derma syndrome, which can present as CREST syndrome
(also called limited systemic sclerosis) and systemic scler-
osis (also called diffuse systemic sclerosis) have been asso-
ciated with severe secondary RP [8]. Our patient, however,
had no features suggestive of CREST syndrome. The pres-
ence of digital tissue ulceration and gangrene associated
with a history of arthralgia in our patient supports the
diagnosis of secondary RP due to a systemic disease, but
owing to some adversities we could not establish a precise
etiology.
The diagnosis of RP in people of black ethnicity can
be challenging. Among others, an important hallmark
for the diagnosis of RP is the presence of a biphasic
color change [1]. This feature is difficult to appreciate in
the absence of an attack and in a dark-skinned patient
like the index case. Indeed, our patient only presented
with pallor of the affected fingers. This raises a potential
limitation of this feature as a major diagnostic criterion
for RP in black Africans. Although capillaroscopy has a
high positive predictive value in detecting the likelihood
of a patient having or developing a connective tissue dis-
ease [9], this could not be performed due to the limita-
tions of our health facility. In addition, a normal ESR
and ASLO and rheumatoid factor concentrations were
not indicative of a systemic disease. Furthermore, an
analysis of ANA and anti-Scl 70 antibodies could not be
done owing to financial constraints and the limited avail-
ability of these tests in Cameroon at the time.
There is currently no cure nor gold standard therapy
for RP [10] even though many advances have been made
as far as pharmacological treatment is concerned [3]. The
management of RP depends on whether it is primary or
secondary, and it generally involves non-pharmacological
and pharmacological measures. Non-pharmacological
treatment entails lifestyle modifications such as avoiding
cold temperatures, emotional stress, caffeine, smoking, and
vasoconstrictive drugs [3]. Lifestyle modification may po-
tentially suffice for the management of primary RP. In cases
where lifestyle modification is inadequate, calcium channel
blockers (CCBs) or topical nitrates can be added [3].
In secondary RP, pharmacological treatment usually
accompanies lifestyle modifications. Iloprost (a prosta-
glandin analog), sildenafil (a phosphodiesterase type 5
inhibitor), topical nitrates (vasodilators), and bosentan
(an endothelin receptor antagonist) could be added to
CCBs for patients who experience persistent intense
pain, ulceration, and gangrene [3]. Iloprost and sildenafil
can reduce the frequency, duration, and severity of
Agbor et al. Journal of Medical Case Reports  (2016) 10:356 Page 3 of 4
attacks, and also improve ulcer healing. Bosentan re-
duces the incidence of new digital ulcers [3]. In patients
with persistent severe ischemia, a surgical consultation
for digital sympathectomy is recommended [8]. With
lifestyle modification and treatment with nifedipine and
sildenafil, signs of ischemia were halted in our patient.
Iloprost was not administered, because it was unavail-
able in local pharmacies.
Unfortunately, our patient presented for treatment
with the ultimate complication of her crisis, gangrene,
affecting several digits. The only treatment available for
gangrene is amputation, resulting in permanent disability.
Conclusions
We have presented a case of severe secondary RP in a
black African woman from a resource-limited setting.
Early diagnosis of this condition and appropriate manage-
ment is pivotal to prevent tissue necrosis and amputation
of the affected digits in extreme cases. The classical bi-
phasic color change during crisis should not be solely re-
lied on to make the diagnosis of RP in black Africans.
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